LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech ...
In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
We are placing coverage of no-moat-rated GenScript under review pending the transfer of coverage to a new analyst. We expect to revisit our coverage of this company over the next three months. Our ...
GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and formulation capabilities with the launch of a GMP-like mRNA manufacturing service, ...
Dr. Hing C. Wong, the Founder and CEO of HCW Biologics, is participating as a panelist at the prestigious 2025 GenScript Biotech Global Forum, highlighting the company's expertise and commitment to ...
The MarketWatch News Department was not involved in the creation of this content. PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D ...
SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...
After a financial maneuver by Legend Biotech, GenScript Biotech no longer considers itself the cell therapy biotech’s majority shareholder. (pengtianli/iStock/Getty ...
PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of ...
PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of ...
Genscript Biotech Corporation ((HK:1548)) has held its Q2 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results